The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer.

Granulocyte colony stimulating factor (G-CSF) was given to 17 patients with advanced breast and ovarian cancer in order to increase the intensity and effectiveness of chemotherapy. Treatment with doxorubicin, at doses of 75 mg m-2 (n = 4 patients), 100 mg m-2 (n = 5), 125 mg m-2 (n = 6) and 150 mg m...

Descripción completa

Detalles Bibliográficos
Autores principales: Bronchud, M. H., Howell, A., Crowther, D., Hopwood, P., Souza, L., Dexter, T. M.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1989
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247341/
https://www.ncbi.nlm.nih.gov/pubmed/2478178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247341/
https://www.ncbi.nlm.nih.gov/pubmed/2478178

Ejemplares similares